MOTTA, IRENE
MOTTA, IRENE
Dipartimento di Scienze Cliniche e di Comunità
Deciphering cytopenias in internal medicine: a single-center observational study
2024 S. Leoni, M. Ferraresi, I. Motta, C. Hu, A.L. Fracanzani, W. Barcellini, B. Fattizzo
Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia
2024 S. Leoni, R. Bou Fakhredin, F. Granata, E. Cassinerio, M. Maggioni, A.L. Fracanzani, M.D. Cappellini, I. Motta
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease
2024 I. Motta, P. Delbini, N. Scaramellini, V. Ghiandai, L. Duca, I. Nava, F. Nascimbeni, S. Lugari, D. Consonni, E. Trombetta, V. Di Stefano, M. Migone De Amicis, E. Cassinerio, F. Carubbi, M.D. Cappellini
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia
2024 D.L. Panzieri, D. Consonni, N. Scaramellini, G. Ausenda, F. Granata, N. Caponio, L. Duca, S. Leoni, S. Elli, M. Ferraresi, V. Bolis, C. Curcio, M.A. Irrera, D. Maira, G. Graziadei, E. Cassinerio, M.D. Cappellini, R. Bou-Fakhredin, V. Brancaleoni, I. Motta
Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease
2024 F. Casarin, R. Mascolo, I. Motta, M.A. Wu, E. Bizzi, A. Pedroli, G. Dieguez, G. Iacomelli, L. Serati, L. Duca, S. Maestroni, E. Tombetti, M.D. Cappellini, A. Brucato
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
2023 A. Aprile, L. Raggi, S. Bolamperti, I. Villa, M. Storto, G. Morello, S. Marktel, C. Tripodo, M.D. Cappellini, I. Motta, A. Rubinacci, G. Ferrari
Anemia management and transfusion strategy in internal medicine units: Less is more
2023 D. Blanca, G. Parrella, D. Consonni, S. Villa, G. Ceriani, A. Cespiati, G. Figini, G. Ghigliazza, D. Maira, G. Oberti, N. Scaramellini, G.L. Schinco, F. Tafuri, N. Montano, M.D. Cappellini, I. Motta
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence
2023 F. Longo, I. Motta, V. Maria Pinto, A. Piolatto, P. Ricchi, I. Tartaglione, R. Origa
Effect of Migalastat on cArdiac InvOlvement in FabRry DiseAse: MAIORA study
2023 A. Camporeale, F. Bandera, M. Pieroni, F. Pieruzzi, M. Spada, A. Bersano, L. Econimo, C. Lanzillo, M. Rubino, R. Mignani, I. Motta, I. Olivotto, I. Tanini, R. Valaperta, K. Chow, I. Baroni, S. Boveri, F. Graziani, S. Pica, L. Tondi, M. Guazzi, M. Lombardi
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
2023 M. Ferraresi, D.L. Panzieri, S. Leoni, M.D. Cappellini, A. Kattamis, I. Motta
Interpreting Iron Homeostasis in Congenital and Acquired Disorders
2023 N. Scaramellini, D. Fischer, A.R. Agarvas, I. Motta, M.U. Muckenthaler, C. Mertens
Drug design and development for rare hematologic diseases
2023 B. Fattizzo, M. Capecchi, I. Motta
Clinical complications and their management
2023 R. Bou-Fakhredin, I. Motta, M.D. Cappellini, A.T. Taher
Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis
2023 M.D. Cappellini, I. Motta, A. Barbato, G. Giuffrida, R. Manna, F. Carubbi, F. Giona
Rise of the planet of rare anemias: An update on emerging treatment strategies
2023 B. Fattizzo, I. Motta
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
2022 A.T. Taher, M.D. Cappellini, A. Kattamis, E. Voskaridou, S. Perrotta, A.G. Piga, A. Filosa, J.B. Porter, T.D. Coates, G.L. Forni, A.A. Thompson, I. Tartaglione, K.M. Musallam, J.T. Backstrom, O. Esposito, A.C. Giuseppi, W.L. Kuo, D. Miteva, J. Lord-Bessen, A. Yucel, T. Zinger, J.K. Shetty, V. Viprakasit, J. Buaboonnam, S. Ekwattanakit, A. Khunhapinant, E. Loka, M. Moraki, P. Flevari, M. Dimopoulou, V. Bartzi, H. Daadaa, G. El Hasbani, S. Koussa, F. Ammendola, S. Scianguetta, M. Puglia, I. Ferrara, G. Ferrero, C. Gaglioti, F. Longo, S. Turrini, V. Voi, E. Cassinerio, A. De, G. Graziadei, A. Marcon, M. Migone De Amicis, I. Motta, P. Cinque, B. Pannone, P. Ricchi, M. Balocco, P. Carrara, F. Della Rovere, M. Lamagna, V. Pinto, S. Quintino, P. Eleftheriou, M. Garbowski, A. de Kreuk, S. Carson, C. Denton, T. Hofstra, S. Veluswamy, J. Wood, S. Badawy, R. Bercovitz, R. Bhat, D. Calamaras, R. Liem, A. Mack
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
2022 I. El-Battrawy, F. Longo, I.J. Nunez Gil, M. Abumayyaleh, B. Gianesin, V. Estrada, A. Aparisi, R. Arroyo-Espliguero, M. Balocco, S. Barella, A. Beccaria, F. Bonetti, M. Casale, E. De michele, A.R. Denotti, C. Fidone, M. Fortini, M.R. Gamberini, G. Graziadei, R. Lisi, A. Massa, A. Marcon, B. Rubinski, M. Miano, I. Motta, V.M. Pinto, A. Piperno, R. Mariani, M.C. Putti, A. Quota, M. Ribersani, M. Marziali, D. Roberti, R. Rosso, I. Tartaglione, A. Vitucci, V. Voi, M. Zecca, R. Romero, C. Marouneld, I. Fernandez-Rozas, C. Espejo, W. Marhaeni, M. Garcia Aguado, M.D. Cappellini, S. Perrotta, L. De Franceschi, A. Piga, G.L. Forni, I. Akin
Advancing the care of β-thalassaemia patients with novel therapies
2022 R. Bou-Fakhredin, I. Motta, M.D. Cappellini
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study
2022 D. Maira, L. Duca, F. Busti, D. Consonni, M. Salvatici, A. Vianello, A. Milani, A. Guzzardella, E. Di Pierro, S. Aliberti, I.M. Baldini, A. Bandera, F. Blasi, E. Cassinerio, M. Cesari, A.L. Fracanzani, G. Grasselli, G. Graziadei, R. Lombardi, G. Marchi, N. Montano, V. Monzani, F. Peyvandi, M. Proietti, M. Sandri, L. Valenti, M.D. Cappellini, D. Girelli, A. Protti, I. Motta
Splenomegaly: Dare to think rare
2022 N. Scaramellini, G. Croci, C. De Magistris, D.L. Panzieri, E. Cassinerio, A. Marcon, F. Nascimbeni, A. Quarta, M.D. Cappellini, I. Motta